Cardiac Myosin Inhibitors and HCM: Therapy of the (Near) Future

March 4, 2022

Robert Colbert Headshot
Robert Colbert, MD
Cardiology Fellow
University of Washington


Grand Rounds Learning Objectives

Upon completion of this program, attendees should be able to:

  • Understand the mechanism of cardiac myosin inhibitors
  • Know the results the recent trials for mavacamten
  • Become aware of future studies